University Medical Centre Ljubljana
Clinical trials sponsored by University Medical Centre Ljubljana, explained in plain language.
-
Weight-Loss Drug's hidden muscle effects under the microscope
Disease control Recruiting nowThis study is investigating how the weight-loss medication tirzepatide affects muscle health in women with obesity. Researchers will give either the medication or a placebo to 30 premenopausal women for 24 weeks and measure changes in body weight, muscle strength, and muscle tiss…
Phase: NA • Sponsor: University Medical Centre Ljubljana • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New heart drug put to the test: can it repair a weakened heart?
Disease control Recruiting nowThis study is testing if adding the drug vericiguat to standard heart failure treatment helps improve the heart's structure and function. It will involve 60 adults with stable but weakened hearts who are already on standard medications. Researchers will compare those receiving th…
Phase: PHASE4 • Sponsor: University Medical Centre Ljubljana • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Can lifting weights help women rebuild strength after a heart attack?
Disease control Recruiting nowThis study aims to find the best exercise plan for women recovering from coronary artery disease or a heart attack. Researchers will compare standard cycling-based rehab to programs that also include weight training, to see which better improves fitness, muscle mass, and quality …
Phase: NA • Sponsor: University Medical Centre Ljubljana • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Personalized stem cell shot tested to heal failing hearts
Disease control Recruiting nowThis small, early-phase study is testing whether a personalized stem cell therapy can help the heart muscle recover in people with severe, chronic heart failure. The 10 participants all have a mechanical heart pump (LVAD) implanted. Researchers will collect a patient's own stem c…
Phase: PHASE2 • Sponsor: University Medical Centre Ljubljana • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Doctors test shorter antibiotic courses for lyme rash
Disease control Recruiting nowThis study aims to find the best amoxicillin dose and treatment length for people with the early skin rash of Lyme disease. Researchers will enroll 510 adults with the rash and randomly assign them to different antibiotic schedules. The goal is to see which approach most effectiv…
Phase: NA • Sponsor: University Medical Centre Ljubljana • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Heart-Saving pill may shield cancer patients from chemo damage
Prevention Recruiting nowThis study is testing whether a drug called dapagliflozin can protect the heart from damage caused by a common type of breast cancer chemotherapy. About 100 women receiving anthracycline chemotherapy will take either dapagliflozin or a placebo pill daily during treatment. Researc…
Phase: PHASE2 • Sponsor: University Medical Centre Ljubljana • Aim: Prevention
Last updated Apr 01, 2026 21:56 UTC
-
Gentler sedation for Tots' stitches? study tests three options
Symptom relief Recruiting nowThis study aims to find the best way to keep young children calm and comfortable during the removal of stitches after cleft lip or palate surgery. It will compare three different sedative medications given by injection or nasal spray in 60 children aged 6 months to 3 years. The g…
Phase: NA • Sponsor: University Medical Centre Ljubljana • Aim: Symptom relief
Last updated Mar 18, 2026 14:53 UTC
-
Scientists probe the Body's hidden blood pressure controls
Knowledge-focused Recruiting nowThis study aims to better understand how the body naturally controls blood pressure and heart rate during activities like standing up and exercising. Researchers will compare these responses between healthy young adults and older adults with high blood pressure. The goal is to ga…
Sponsor: University Medical Centre Ljubljana • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC
-
Global quest to map rare brain Disorder's journey
Knowledge-focused Recruiting nowThis study aims to understand how CTNNB1 syndrome, a rare genetic condition affecting brain development, changes over a person's lifetime. Researchers will follow 250 children and adults with the condition for five years, tracking their physical, mental, and social development. T…
Sponsor: University Medical Centre Ljubljana • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC